Renaissance Technologies - AVENUE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$34,000
-80.7%
124,400
+5.3%
0.00%
Q3 2021$176,000
-10.7%
118,100
+50.8%
0.00%
Q2 2021$197,000
-76.0%
78,314
+3.1%
0.00%
-100.0%
Q3 2020$822,000
-38.3%
75,941
-38.6%
0.00%0.0%
Q2 2020$1,333,000
+123.3%
123,763
+85.5%
0.00%0.0%
Q1 2020$597,000
+393.4%
66,735
+431.6%
0.00%
Q4 2019$121,000
+19.8%
12,553
-22.0%
0.00%
Q2 2019$101,000
+98.0%
16,100
+49.0%
0.00%
Q1 2019$51,00010,8080.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders